Sun-Woo Hong
Chief Executive Officer at mCureX Therapeutics, Inc.
Net worth: 706 890 $ as of 29/04/2024
Profile
Sun-Woo Hong is currently the Chief Executive Officer at mCureX Therapeutics, Inc. Prior to this, he worked as the Director, Senior Managing Director & Head-Research at OliX Pharmaceuticals, Inc. Dr. Hong completed his undergraduate and doctorate degrees from Pohang University of Science & Technology and his graduate degree from Korea University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/03/2024 | 62,348 ( 0.38% ) | 706 890 $ | 29/04/2024 |
Sun-Woo Hong active positions
| Companies | Position | Start |
|---|---|---|
mCureX Therapeutics, Inc.
 mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Chief Executive Officer | 31/12/2020 |
Former positions of Sun-Woo Hong
| Companies | Position | End |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Director/Board Member | - |
Training of Sun-Woo Hong
| Pohang University of Science & Technology | Doctorate Degree |
| Korea University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OLIX PHARMACEUTICALS, INC | Health Technology |
| Private companies | 1 |
|---|---|
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Health Technology |
- Stock Market
- Insiders
- Sun-Woo Hong
